SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tnsaf who wrote (1462)2/10/2002 6:25:46 PM
From: tnsaf  Read Replies (1) of 7143
 
Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

Proc. Natl. Acad. Sci. USA, Vol. 99, Issue 3, 1491-1496, February 5, 2002

Giovanna Angelini*,, Stefania Gardella*, Massimo Ardy*, Maria Rosa Ciriolo, Giuseppe Filomeni, Giovanna Di Trapani§, Frank Clarke§, Roberto Sitia¶, and Anna Rubartelli*
* Protein Biology Unit, National Cancer Research Institute, 16132 Genoa, Italy; Department of Biomedical Sciences, University of Chieti, 66100 Chieti, Italy; § School of Biomolecular and Biomedical Science, Griffith University, Brisbane 4111, Australia; and ¶ Università Vita-Salute San Raffaele, 20132 Milan, Italy

T lymphocytes are defective in cystine uptake and thus require exogenous thiols for activation and function. Here we show that monocyte-derived human dendritic cells (DCs) release cysteine in the extracellular space. Cysteine generation is increased by lipopolysaccharide and tumor necrosis factor , and by contact with T cells specifically recognizing soluble or alloantigens. These stimuli also induce thioredoxin (TRX) accumulation in DCs. However, only the contact with antigen-specific T cells triggers TRX secretion by the antigen-presenting cells. Fewer extracellular thiols are recovered after DC-T cell interactions when cystine uptake or TRX activity are inhibited. In addition, glutamate (Glu) and anti-TRX-inactivating antibodies inhibit antigen-dependent T lymphocyte proliferation. These findings indicate that, during antigen presentation, DCs uptake cystine and release cysteine and TRX, thus providing a reducing microenvironment that facilitates immune response.
------------------------------------------------------------
www.pnas.org/cgi/doi/10.1073/pnas.022630299
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext